» Articles » PMID: 38842549

[Reversible Cerebral Vasoconstriction Syndrome : A rare Cause of Stroke]

Overview
Journal Nervenarzt
Specialty Neurology
Date 2024 Jun 6
PMID 38842549
Authors
Affiliations
Soon will be listed here.
Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a complex and etiologically diverse neurovascular disorder that typically presents with severe thunderclap headaches (TCH) as the primary symptom, accompanied by reversible vasoconstriction of the cerebral arteries. The clinical course may include focal neurological deficits or epileptic seizures. There are two types: idiopathic RCVS and secondary RCVS, the latter triggered by various substances, medical interventions, or diseases. In clinical practice, various medical specialists may initially encounter this condition, underscoring the importance of accurate recognition and diagnosis of RCVS. The clinical course often appears monophasic and self-limiting, with recurrences reported in only 1.7% of cases annually. Complications such as cerebral hemorrhages and cerebral ischemia can lead to death in 5-10% of cases. This article utilizes a case study to explore RCVS, its complications, and the diagnostic procedures involved.

References
1.
Valencia-Mendoza M, Ramirez-Rodriguez N, Vargas-Avila N, Pena-Ortiz A, Corzo-Villamizar M, Serna-Ramirez L . Fatal reversible cerebral vasoconstriction syndrome: A systematic review of case series and case reports. J Clin Neurosci. 2019; 70:183-188. DOI: 10.1016/j.jocn.2019.08.014. View

2.
Perillo T, Paolella C, Perrotta G, Serino A, Caranci F, Manto A . Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. Radiol Med. 2022; 127(9):981-990. PMC: 9362037. DOI: 10.1007/s11547-022-01532-2. View

3.
Caria F, Zedde M, Gamba M, Bersano A, Rasura M, Adami A . The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS). Cephalalgia. 2019; 39(10):1267-1276. DOI: 10.1177/0333102419849013. View

4.
John S, Singhal A, Calabrese L, Uchino K, Hammad T, Tepper S . Long-term outcomes after reversible cerebral vasoconstriction syndrome. Cephalalgia. 2015; 36(4):387-94. DOI: 10.1177/0333102415591507. View

5.
Magid-Bernstein J, Omran S, Parikh N, Merkler A, Navi B, Kamel H . Reversible Cerebral Vasoconstriction Syndrome: Symptoms, Incidence, and Resource Utilization in a Population-Based US Cohort. Neurology. 2021; 97(3):e248-e253. PMC: 8302148. DOI: 10.1212/WNL.0000000000012223. View